Search

everythinglearnresearchcommunity

for

Search:↓

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

The normal human prostate does not significantly affect blood DHT levels.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.